CFTR and cystic fibrosis: Altered miRNA pathways couldexplain major disorders associated with CFTR mutations.35 Thus, miRNAs could be a novel therapeutic targetfor the management of CF and CF-related pathologies such as diabetes,liver fibrosis, and pancreatic adenocarcinoma.